244 related articles for article (PubMed ID: 34029872)
1. Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in waters via surface enhanced Raman scattering (SERS).
Zhang D; Zhang X; Ma R; Deng S; Wang X; Wang X; Zhang X; Huang X; Liu Y; Li G; Qu J; Zhu Y; Li J
Water Res; 2021 Jul; 200():117243. PubMed ID: 34029872
[TBL] [Abstract][Full Text] [Related]
2. Rapid Detection of SARS-CoV-2 Variants Using an Angiotensin-Converting Enzyme 2-Based Surface-Enhanced Raman Spectroscopy Sensor Enhanced by CoVari Deep Learning Algorithms.
Yang Y; Cui J; Luo D; Murray J; Chen X; Hülck S; Tripp RA; Zhao Y
ACS Sens; 2024 Jun; 9(6):3158-3169. PubMed ID: 38843447
[TBL] [Abstract][Full Text] [Related]
3. Label-Free Detection of the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein at Physiologically Relevant Concentrations Using Surface-Enhanced Raman Spectroscopy.
Sarychev AK; Sukhanova A; Ivanov AV; Bykov IV; Bakholdin NV; Vasina DV; Gushchin VA; Tkachuk AP; Nifontova G; Samokhvalov PS; Karaulov A; Nabiev I
Biosensors (Basel); 2022 May; 12(5):. PubMed ID: 35624601
[TBL] [Abstract][Full Text] [Related]
4. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
5. Model of the SARS-CoV-2 Virus for Development of a DNA-Modified, Surface-Enhanced Raman Spectroscopy Sensor with a Novel Hybrid Plasmonic Platform in Sandwich Mode.
Samodelova MV; Kapitanova OO; Meshcheryakova NF; Novikov SM; Yarenkov NR; Streletskii OA; Yakubovsky DI; Grabovenko FI; Zhdanov GA; Arsenin AV; Volkov VS; Zavyalova EG; Veselova IA; Zvereva MI
Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140152
[TBL] [Abstract][Full Text] [Related]
6. Plasmonic nanostructure-enhanced Raman scattering for detection of SARS-CoV-2 nucleocapsid protein and spike protein variants.
Yeh YJ; Le TN; Hsiao WW; Tung KL; Ostrikov KK; Chiang WH
Anal Chim Acta; 2023 Jan; 1239():340651. PubMed ID: 36628748
[TBL] [Abstract][Full Text] [Related]
7. Directly and ultrasensitivity detecting SARS-CoV-2 spike protein in pharyngeal swab solution by using SERS-based biosensor.
Liu Y; Qin Z; Jia X; Zhou J; Li H; Wang X; Chen Y; Deng J; Jin Z; Wang G
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Dec; 303():123275. PubMed ID: 37611522
[TBL] [Abstract][Full Text] [Related]
8. Surface-enhanced Raman scattering-based immunoassay for severe acute respiratory syndrome coronavirus 2.
Cha H; Kim H; Joung Y; Kang H; Moon J; Jang H; Park S; Kwon HJ; Lee IC; Kim S; Yong D; Yoon SW; Park SG; Guk K; Lim EK; Park HG; Choo J; Jung J; Kang T
Biosens Bioelectron; 2022 Apr; 202():114008. PubMed ID: 35086030
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
11. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
[TBL] [Abstract][Full Text] [Related]
12. Synergistic surface-enhanced Raman scattering effect to distinguish live SARS-CoV-2 S pseudovirus.
Sitjar J; Xu HZ; Liu CY; Wang JR; Liao JD; Tsai HP; Lee H; Liu BH; Chang CW
Anal Chim Acta; 2022 Feb; 1193():339406. PubMed ID: 35058004
[TBL] [Abstract][Full Text] [Related]
13. Catching COVID: Engineering Peptide-Modified Surface-Enhanced Raman Spectroscopy Sensors for SARS-CoV-2.
Payne TD; Klawa SJ; Jian T; Kim SH; Papanikolas MJ; Freeman R; Schultz ZD
ACS Sens; 2021 Sep; 6(9):3436-3444. PubMed ID: 34491043
[TBL] [Abstract][Full Text] [Related]
14. Sensitive Detection of SARS-CoV-2 Using a SERS-Based Aptasensor.
Chen H; Park SG; Choi N; Kwon HJ; Kang T; Lee MK; Choo J
ACS Sens; 2021 Jun; 6(6):2378-2385. PubMed ID: 34019385
[TBL] [Abstract][Full Text] [Related]
15. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
17. Ultrasensitive detection of SARS-CoV-2 S protein with aptamers biosensor based on surface-enhanced Raman scattering.
Gu MM; Guan PC; Xu SS; Li HM; Kou YC; Lin XD; Kathiresan M; Song Y; Zhang YJ; Jin SZ; Li JF
J Chem Phys; 2023 Jan; 158(2):024203. PubMed ID: 36641419
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Receptor Binding Domain as a Stable-Potential Target for SARS-CoV-2 Detection by Surface-Enhanced Raman Spectroscopy.
Awada C; Abdullah MMB; Traboulsi H; Dab C; Alshoaibi A
Sensors (Basel); 2021 Jul; 21(13):. PubMed ID: 34283162
[TBL] [Abstract][Full Text] [Related]
19. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
[TBL] [Abstract][Full Text] [Related]
20. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
